RHONDA DAVIS: Open Payments
NPI 1326306358 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 21 payments from 3 companies in 2025. Trend: 2023 $173 · 2024 $368 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $380 |
| Neurocrine BioSciences, Inc. | 3 | $337 |
| Novo Nordisk Inc | 1 | $29 |
Products named: REXULTI, INGREZZA, Ozempic.
Industry payments across AL — which companies pay providers there.
